MSH2 and osteosarcoma: Reinforcing this increased risk of osteosarcomas, recently Mirabello et al. [41] investigated germline causes of 1244 patients with osteosarcoma and identified more germline MSH2 pathogenic variants in cases than in the control cohorts (p < 0.05).